(BZO) Benzodiazepine Test (Cassette) GBR-3412

Note:Could be customized under your request

Specifications

1. High sensitivity, simple, easy.

2. Accuracy: >99%.

3. CE & ISO approved.

4. Specimen: Urine.

5. Model No:BZO-U02D

1.Application

The BZO Rapid Test Device (Urine) detects Benzodiazepines through visual interpretation of color development
on the Device. Drug conjugates are immobilized on the test region of the membrane. During testing, the specimen
reacts with antibodies conjugated to colored particles and precoated on the sample pad. The mixture then
migratesthrough the membrane by capillary action, and interacts with reagents on the membrane. If there are
insufficient drug molecules in the specimen, the antibody-colored particle conjugate will bind to the drug conjugates,
forming a colored band at the test region of the membrane. Therefore, a colored band appears in the test region
when the urine is negative for the drug. If drug molecules are present in the urine above the cut-off concentration
of the test, they compete with the immobilized drug conjugate on the test region for limited antibody binding sites.
This will prevent attachment of the antibody-colored particle conjugate to the test region. Therefore, the absence
of a colored band at the test region indicates a positive result. The appearance of a colored band at the control
region serves as a procedural control, indicating that the proper volume of specimen has been added and
membrane wicking has occurred.

2. Usage:
Allow test device,urine specimen,and/or controls to equilibrate to room temperature (15-30°C) prior to testing.